231 related articles for article (PubMed ID: 20305539)
1. A diagnostic challenge: mild hemophilia B with normal activated partial thromboplastin time.
Park CH; Seo JY; Kim HJ; Jang JH; Kim SH
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):368-71. PubMed ID: 20305539
[TBL] [Abstract][Full Text] [Related]
2. Mild haemophilia B from a novel missense mutation Ser350Ala of the F9 gene.
Park CH; Seo JY; Kim SH; Koo HH; Kim HJ
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):544-6. PubMed ID: 23492913
[TBL] [Abstract][Full Text] [Related]
3. Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B.
Wang X; Tang N; Shen N; Zhu Y; Lu Y; Gao L
Hematology; 2020 Dec; 25(1):484-488. PubMed ID: 33295842
[TBL] [Abstract][Full Text] [Related]
4. A novel missense mutation in F9 gene causes hemophilia B in a family with clinical variability.
Yi S; Yang Q; Zuo Y; Li M; Luo J; Qin Z; Zhang Q; Li M; Huang L; Lu Y; Feng S; Fan X
Blood Coagul Fibrinolysis; 2020 Mar; 31(2):121-126. PubMed ID: 31904612
[TBL] [Abstract][Full Text] [Related]
5. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
[TBL] [Abstract][Full Text] [Related]
6. Factor IX Denver, ASN 346-->ASP mutation resulting in a dysfunctional protein with defective factor VIIIa interaction.
Lefkowitz JB; Nuss R; Haver T; Jacobson L; Thompson AR; Manco-Johnson M
Thromb Haemost; 2001 Sep; 86(3):862-70. PubMed ID: 11583320
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
[TBL] [Abstract][Full Text] [Related]
8. [Gene diagnosis of 3 haemophilia B families].
Zhang Y; Yang LH; Lu YL; Ding QL; Wang XF; Liu XE; Zhang L
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):179-82. PubMed ID: 18788618
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B.
Knobe KE; Persson KE; Sjörin E; Villoutreix BO; Ljung RC
Pathophysiol Haemost Thromb; 2006; 35(5):370-5. PubMed ID: 17230038
[TBL] [Abstract][Full Text] [Related]
10. Molecular genotyping of the Italian cohort of patients with hemophilia B.
Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
[TBL] [Abstract][Full Text] [Related]
11. [Unusual postoperative hemorrhage in a patient with ruptured aneurysm and hemophilia B].
Komatsu Y; Narushima K; Kobayashi E; Nose T; Maki Y
No Shinkei Geka; 1988 Oct; 16(11):1281-5. PubMed ID: 3211277
[TBL] [Abstract][Full Text] [Related]
12. Identification of mutations in the F9 gene including exon deletion by multiplex ligation-dependent probe amplification in 33 unrelated Korean patients with haemophilia B.
Kwon MJ; Yoo KY; Kim HJ; Kim SH
Haemophilia; 2008 Sep; 14(5):1069-75. PubMed ID: 18624698
[TBL] [Abstract][Full Text] [Related]
13. [An uncommon cause of severe soft tissue bleeding during phenprocoumon treatment].
Neuhaus T; Hertfelder HJ; Hess L; Oldenburg J; Walger P; Vetter H
Dtsch Med Wochenschr; 2001 Jun; 126(25-26):754-6. PubMed ID: 11455667
[TBL] [Abstract][Full Text] [Related]
14. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
[TBL] [Abstract][Full Text] [Related]
15. Influence of source of phospholipids for APTT-based factor IX assays and potential consequences for the diagnosis of mild haemophilia B.
Pouplard C; Trossaert M; LE Querrec A; Delahousse B; Giraudeau B; Gruel Y
Haemophilia; 2009 Jan; 15(1):365-8. PubMed ID: 18811593
[No Abstract] [Full Text] [Related]
16. Six novel and three recurrent mutations in nine Austrian patients with hemophilia B.
Walter J; Pabinger-Fasching I; Watzke HH
Thromb Haemost; 1994 Jul; 72(1):74-7. PubMed ID: 7974379
[TBL] [Abstract][Full Text] [Related]
17. Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
Sharathkumar A; Hardesty B; Greist A; Salter J; Kerlin B; Heiman M; Sulkin M; Shapiro A
Haemophilia; 2009 Jan; 15(1):91-100. PubMed ID: 18721150
[TBL] [Abstract][Full Text] [Related]
18. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation.
Herzog RW; Mount JD; Arruda VR; High KA; Lothrop CD
Mol Ther; 2001 Sep; 4(3):192-200. PubMed ID: 11545609
[TBL] [Abstract][Full Text] [Related]
19. Novel deleterious mutation in the F12 gene in a Korean family with severe coagulation factor XII deficiency.
Kim HJ; Kim HJ; Kwon EH; Lee KO; Park IA; Kim SH
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):683-6. PubMed ID: 20729721
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B.
Kao CY; Lin CN; Yang YL; Hamaguchi N; Yang SJ; Shen MC; Kao JT; Lin SW
Thromb Haemost; 2011 Apr; 105(4):616-26. PubMed ID: 21301787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
